Long-term Persistence of Zoster Vaccine Efficacy
Author(s) -
Vicki A. Morrison,
Gary R. Johnson,
Kenneth E. Schmader,
Myron J. Levin,
Jane H. Zhang,
David J. Looney,
Robert F. Betts,
Larry Gelb,
John Guatelli,
Ruth Harbecke,
Connie Pachucki,
Susan Keay,
Barbara E. Menzies,
Marie R. Griffin,
Carol A. Kauffman,
Adriana Marques,
John Toney,
Kathy D. Boardman,
ShuChih Su,
Xiaoming Li,
Ivan S. F. Chan,
Janie Parrino,
Paula W. Annunziato,
Michael N. Oxman,
LE. Davis,
CA Kauffman,
S. Keay,
SE Straus,
AR Marques,
NE Soto,
P. A. Brunell,
J. W. Gnann,
Rosário Serrão,
D. J. Cotton,
R.P. Goodman,
RD Arbeit,
C. T. Pachucki,
M J Levin,
KE Schmader,
W Keitel,
RN Greenberg,
VA Morrison,
PF Wright,
MR Griffin,
MS Simberkoff,
S-s Yeh,
Zeena Lobo,
Mark Holodniy,
J. F. Loutit,
Betts Rf,
LD Gelb,
G. E. Crawford,
J C Guatelli,
Paul Brooks,
D. J. Looney,
K M Neuzil,
JF Toney,
B Menzies
Publication year - 2014
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciu918
Subject(s) - medicine , persistence (discontinuity) , shingles , vaccine efficacy , vaccination , virology , pediatrics , virus , geotechnical engineering , engineering
The Shingles Prevention Study (SPS) demonstrated zoster vaccine efficacy through 4 years postvaccination. A Short-Term Persistence Substudy (STPS) demonstrated persistence of vaccine efficacy for at least 5 years. A Long-Term Persistence Substudy (LTPS) was undertaken to further assess vaccine efficacy in SPS vaccine recipients followed for up to 11 years postvaccination. Study outcomes were assessed for the entire LTPS period and for each year from 7 to 11 years postvaccination.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom